Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response

Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive...

Full description

Bibliographic Details
Main Authors: Marco Dioguardi Burgio, Riccardo Sartoris, Claudia Libotean, Magaly Zappa, Annie Sibert, Valérie Vilgrain, Maxime Ronot
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cancer Imaging
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40644-019-0260-2
_version_ 1818614864712564736
author Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
author_facet Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
author_sort Marco Dioguardi Burgio
collection DOAJ
description Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated.
first_indexed 2024-12-16T16:24:47Z
format Article
id doaj.art-e6f54bac0d2a40daa668cce9cfa4c726
institution Directory Open Access Journal
issn 1470-7330
language English
last_indexed 2024-12-16T16:24:47Z
publishDate 2019-11-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj.art-e6f54bac0d2a40daa668cce9cfa4c7262022-12-21T22:24:47ZengBMCCancer Imaging1470-73302019-11-011911910.1186/s40644-019-0260-2Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete responseMarco Dioguardi Burgio0Riccardo Sartoris1Claudia Libotean2Magaly Zappa3Annie Sibert4Valérie Vilgrain5Maxime Ronot6Department of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineAbstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated.http://link.springer.com/article/10.1186/s40644-019-0260-2Carcinoma, hepatocellularEthiodized oilChemoembolization, therapeutic
spellingShingle Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
Cancer Imaging
Carcinoma, hepatocellular
Ethiodized oil
Chemoembolization, therapeutic
title Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_full Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_fullStr Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_full_unstemmed Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_short Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_sort lipiodol retention pattern after tace for hcc is a predictor for local progression in lesions with complete response
topic Carcinoma, hepatocellular
Ethiodized oil
Chemoembolization, therapeutic
url http://link.springer.com/article/10.1186/s40644-019-0260-2
work_keys_str_mv AT marcodioguardiburgio lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT riccardosartoris lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT claudialibotean lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT magalyzappa lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT anniesibert lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT valerievilgrain lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT maximeronot lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse